Entropy Neurodynamics Limited has released a press release.
Securures Ethics Approval for Plexoval Clinical Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Entropy Neurodynamics Limited on 6ix
Earlier from Entropy Neurodynamics
- Market Update
- Explainer The critical bottleneck of exosome isolation
- Appendix 4D and Interim Financial Report - Dec 18 Half Year
- Positive outcomes in first animal study involving Plexaris
- December 2018 Quarterly Cash Flow Report
Later from Entropy Neurodynamics
- Share Placement and Share Purchase Plan Announced
- Share Purchase Plan 2019 Offer Document
- PLEXOVAL Exosome Wound Healing Human Study Starts
- Appendix 4E and Annual Financial Report FY 2019
- Appendix 4C - quarterly
Follow Entropy Neurodynamics into a list and get an email when it puts out news.
Follow Entropy Neurodynamics